Follow

Submissions from 2024

 

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors, Bruno Bastos

 

Ganglion Cysts Arising From the Proximal Tibiofibular Joint: Treatment Approach and Associated Outcomes-A Systematic Review, Juan Pretell

 

Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions, Arun Maharaj and Manmeet Ahluwalia

 

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

 

Implementation Strategies to Promote Short-Course Radiation for Bone Metastases, Rahul Kumar and Joseph Panoff

 

Implementation Strategies to Promote Short-Course Radiation for Bone Metastases, Joseph Panoff

 

Improving Medical Student Performance With Unsupervised Simulation and Remote Asynchronous Feedback, Domenech Asbun

PDF

International survey on opinions and use of robot-assisted and laparoscopic minimally invasive pancreatic surgery: 5-year follow up, Horacio Asbun

 

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval-Leon

 

Management of Postoperative Discitis with Debridement and Novel Technique of Local Antibiotic Instillation: Functional Outcomes from a Resource-Limited Setting, Ahmad Ozair

 

MASCC/ISOO Clinical Practice Statement: Management of oral complications of targeted therapy, Alessandro Villa

 

Minimally Invasive and Cost-Effective Access to Deep-Seated Intracranial Lesions Using 19F Peel-Away Sheath Introducer and "Dynamic" Retraction: Technical Note and a Case Series, Michael McDermott, Andrea Castaldi, and Vitaly Siomin

 

MRI-Guided Adaptive Radiation Therapy, Michael Chuong

PDF

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial, Alessandro Villa

 

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

 

Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer, Alessandro Villa

 

OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL, Yuliya Linhares

 

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

 

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Rohan Garje and Bruno Bastos

 

Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez and Eduardo Pons

 

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

 

Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases, Manmeet Ahluwalia

 

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

 

Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria, Horacio Asbun

 

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun